Association Between VDR Polymorphisms and Breast Cancer: An Updated and Comparative Meta-analysis of Crude and Adjusted Odd Ratios |
Huang, Qian-Qian
(Guangdong Key Laboratory of Molecular Epidemiology, School of Public Health, Guangdong Pharmaceutical University)
Liao, Yu-Yi (Guangdong Key Laboratory of Molecular Epidemiology, School of Public Health, Guangdong Pharmaceutical University) Ye, Xiao-Hua (Guangdong Key Laboratory of Molecular Epidemiology, School of Public Health, Guangdong Pharmaceutical University) Fu, Jin-Jian (Liuzhou Municipal Maternity and Child Healthcare Hospital) Chen, Si-Dong (Guangdong Key Laboratory of Molecular Epidemiology, School of Public Health, Guangdong Pharmaceutical University) |
1 | Wells GA, Shea B, O'Connell D, et al (2011). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 28 August 2013]. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. |
2 | Yao S, Zirpoli G, Bovbjerg DH, et al (2012). Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res, 14, R58. DOI |
3 | Zhou ZC, Wang J, Cai ZH, et al (2013). Association between vitamin D receptor gene Cdx2 polymorphism and breast cancer susceptibility. Tumour Biol, doi:10.1007/s13277-013-0919-4. DOI |
4 | John EM, Schwartz GG, Koo J, et al (2007). Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol, 166, 1409-19. DOI ScienceOn |
5 | Huang J, Huang J, Ma Y, et al (2013). The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis. Mol Biol Rep, 40, 4219-25. DOI |
6 | Huang J, Yang J, Wang H, et al (2013). The association between the poly(A) polymorphism in the VDR gene and cancer risk: a meta-analysis. Tumour Biol, 34, 1833-8. DOI |
7 | Ingles SA, Garcia DG, Wang W, et al (2000). Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control, 11, 25-30. DOI ScienceOn |
8 | Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. DOI ScienceOn |
9 | Lopes N, Sousa B, Martins D, et al (2010). Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer, 10, 483. DOI |
10 | VandeVord PJ, Wooley PH, Darga LL, et al (2006). Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat, 100, 103-7. DOI |
11 | Wang H, Wang W, Yang D, Wang S (2013). TaqI polymorphism of VDR gene contributes to breast cancer risk. Tumour Biol, doi:10.1007/s13277-013-1011-9. DOI |
12 | Wang J, He Q, Shao YG, et al (2013). Associations between vitamin D receptor polymorphisms and breast cancer risk. Tumour Biol, doi:10.1007/s13277-013-0967-9. DOI |
13 | Wedren S, Magnusson C, Humphreys K, et al (2007). Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 16, 1775-83. DOI |
14 | Duval S, Tweedie R (2000). Trim and fill: A simple funnel-plotbased method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455-63. DOI ScienceOn |
15 | Curran JE, Vaughan T, Lea RA, et al (1999). Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer, 83, 723-6. DOI |
16 | Fuhrman BJ, Freedman DM, Bhatti P, et al (2013). Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res, 33, 543-51. |
17 | Dalessandri KM, Miike R, Wiencke JK, et al (2012). Vitamin D receptor polymorphisms and breast cancer risk in a highincidence population: a pilot study. J Am Coll Surg, 215, 652-7. DOI |
18 | Dunning AM, McBride S, Gregory J, et al (1999). No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis, 20, 2131-5. DOI ScienceOn |
19 | Engel LS, Orlow I, Sima CS, et al (2012). Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev, 21, 1856-67. DOI ScienceOn |
20 | Gapska P, Scott RJ, Serrano-Fernandez P, et al (2009). Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat, 115, 629-33. DOI |
21 | Guy M, Lowe LC, Bretherton-Watt D, et al (2004). Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res, 10, 5472-81. DOI |
22 | Hefler LA, Tempfer CB, Grimm C, et al (2004). Estrogenmetabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer, 101, 264-9. DOI ScienceOn |
23 | Hou MF, Tien YC, Lin GT, et al (2002). Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat, 74, 1-7. DOI ScienceOn |
24 | Anderson LN, Cotterchio M, Cole DE, Knight JA (2011). Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev, 20, 1708-17. DOI |
25 | Bretherton-Watt D, Given-Wilson R, Mansi JL, et al (2001). Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer, 85, 171-5. DOI ScienceOn |
26 | Tang C, Chen N, Wu M, et al (2009). Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat, 117, 391-9. DOI |
27 | Trabert B, Malone KE, Daling JR, et al (2007). Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res, 9, R84. DOI |
28 | Abbas S, Nieters A, Linseisen J, et al (2008). Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res, 10, R31. DOI |
29 | Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N (2003). Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med, 35, 550-5. DOI |
30 | Chakraborty A, Mishra AK, Soni A, et al (2009). Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev, 32, 386-94. DOI |
31 | Chen WY, Bertone-Johnson ER, Hunter DJ, et al (2005). Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 2335-9. DOI |
32 | Cui J, Shen K, Shen Z, et al (2001). [Relationship of vitamin D receptor polymorphism with breast cancer]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 18, 286-8. |
33 | Rollison DE, Cole AL, Tung KH, et al (2012). Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat, 132, 683-91. DOI |
34 | Shab-Bidar S, Neyestani TR, Djazayery A (2011). Efficacy of vitamin D3-fortified-yogurt drink on anthropometric, metabolic, inflammatory and oxidative stress biomarkers according to vitamin D receptor gene polymorphisms in type 2 diabetic patients: a study protocol for a randomized controlled clinical trial. BMC Endocr Disord, 11, 12. DOI |
35 | McKay JD, McCullough ML, Ziegler RG, et al (2009). Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev, 18, 297-305. DOI |
36 | Mishra DK, Wu Y, Sarkissyan M, et al (2013). Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One, 8, e57967. DOI |
37 | Newcomb PA, Kim H, Trentham-Dietz A, et al (2002). Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1503-4. |
38 | Shahbazi S, Alavi S, Majidzadeh-A K, et al (2013). BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol, 30, 393. DOI |
39 | Sillanpaa P, Hirvonen A, Kataja V, et al (2004). Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics, 14, 239-45. DOI |
40 | Sinotte M, Rousseau F, Ayotte P, et al (2008). Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer, 15, 975-83. DOI |
41 | McCullough ML, Stevens VL, Diver WR, et al (2007). Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res, 9, R9. DOI |
42 | McCullough ML, Bostick RM, Mayo TL (2009). Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr, 29, 111-32. DOI ScienceOn |
43 | Lowe LC, Guy M, Mansi JL, et al (2005). Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer, 41, 1164-9. DOI |
44 | Lundin AC, Soderkvist P, Eriksson B, et al (1999). Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res, 59, 2332-4. |